McKesson (MEX:MCK) Dividends Received


MEX:MCK McKesson Corp MEX:MCK
73 GF Score
Price MXN14,083.59
GF Value MXN14,286.09
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is McKesson Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

MEX:MCK
73GF Score
McKesson Corp MEX:MCK
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is McKesson (MEX:MCK) Overvalued in 2026?

Based on GuruFocus' analysis, McKesson stock appears to be undervalued. The current stock price of MXN14,083.59 is trading 1.4% below its estimated GF Value™ of MXN14,286.09. GuruFocus considers McKesson to be Fairly Valued.

Key valuation signals for MEX:MCK:

  • Dividends Received:
  • GF Value™: MXN14,286.09 vs. price of MXN14,083.59 (1.4% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the MEX:MCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

McKesson Business Description

Address 6555 State Highway 161, Irving, TX, USA, 75039
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
73GF Score

Get the complete analysis for MEX:MCK

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN14,083.59
Price
MXN14,286.09
GF Value